No Data
No Data
No Data
No Data
No Data
Liver Cirrhosis Pipeline Insights, 2024: Featuring 45+ Companies and 50+ Pipeline Drugs, Including Elafibranor (Ipsen), Volixibat (Mirum Pharmaceuticals), and PVT201 (Parvus Therapeutics)
Yahoo FinanceApr 26 09:42 ET
Stifel Starts Mirum at Buy, Cites IBATi Drug Potential
Seeking AlphaApr 18 10:39 ET
Express News | Mirum Pharmaceuticals Inc : Stifel Initiates Coverage With Buy Rating; Target Price $48
Moomoo 24/7Apr 17 06:40 ET
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) today announced that on April 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase
BusinesswireApr 10 21:30 ET
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Natera (NTRA) and Mirum Pharmaceuticals (MIRM)
TipRanksApr 10 02:11 ET
Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM) and Rocket Pharmaceuticals (RCKT)
TipRanksApr 2 11:50 ET
No Data
No Data
SpyderCall : Very valuable info as usual. Thanks for the hard work.
shintaka1168 : こんな情報を配信してくれるなんて、おどろきました。これからもチェックしようと思います